FMP
Acasti Pharma Inc.
ACST
NASDAQ
Inactive Equity
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
3.37 USD
0.13 (3.86%)
About
ceo
Mr. Prashant Kohli
sector
Healthcare
industry
Biotechnology
website
https://www.acastipharma.comexchange
NASDAQ
Description
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
CIK
0001444192
ISIN
CA00430K8656
CUSIP
00430K402
Address
3009 boulevard de la Concorde ...
Phone
450 687 2262
Country
CA
Employee
32
IPO Date
Feb 7, 2012
Key Executives
